News Focus
News Focus
icon url

flipper44

01/21/25 7:36 PM

#744768 RE: Doc logic #744764

Harvard/NWBO workaround are hyperactivated dendritic cells (for Direct and L), which utilize manufacturing with inflammasomes in vitro. Patent if granted (I think it will be), goes out to 2040.

My guess is BP knows very well what the careful five years of preclinical research means.

That said, as FeMike also tends to think, it’s probably already all penciled in and awaiting a trigger event like approval of L.
icon url

skitahoe

01/21/25 8:18 PM

#744770 RE: Doc logic #744764

Doc, I could certainly be wrong, but I believe that neither of the DCVax's are totally curative by themselves. I will take products, largely from the BP's in addition to them to reach cures. Certainly, in some cases their current products may no longer be part of the SOC, but it's very likely that new products will be added, or developed and added that lead to far greater cure rates than reached with the SOC without the DCVax's.

When you look at the benefit of a patient living many years, perhaps decades after onset of a disease vs. a few years ending in death, the BP's will have a much greater opportunity to sell products to the longer living patients.

If the BP's are truly fighting the DCVax's, short term is may have benefits for certain products, but long term they're the losers. It's penny wise and pound foolish.

Gary
Bullish
Bullish
icon url

Riley4

01/21/25 11:03 PM

#744807 RE: Doc logic #744764

Stall, almost hilarious, you are being overly generous c big money moves against competition. I’ve talked to so many MD’s that have been offered money to back drugs, at least 10 MD’s actually said to me they didn’t trust what certain big pharma’s were pushing. Tough for MD as so much money involved. For this I can’t imagine. Last weekend filled in as supervisor for Vanderbilt outlying hospital TN and engaged couple of very intelligent ER MD’s, they never heard of nwbo, but both said could understand that hard to fight status quo unless earth moving. They both said would look into. I guess the more MD’s I engage could help on small scale? Of course only comes from nurse supervisor, but I think most of the MD’s respect my opinions after 30 yrs. A few still call me after rec FB after mandatory holding period on stock and hit around $25, we all have done well on that one. I see this one much much bigger, but being so unknown not pushed as hard, only make info available